DK3524255T3 - Sammensætning til behandling af acne - Google Patents

Sammensætning til behandling af acne Download PDF

Info

Publication number
DK3524255T3
DK3524255T3 DK19161351.2T DK19161351T DK3524255T3 DK 3524255 T3 DK3524255 T3 DK 3524255T3 DK 19161351 T DK19161351 T DK 19161351T DK 3524255 T3 DK3524255 T3 DK 3524255T3
Authority
DK
Denmark
Prior art keywords
acne
treatment
composition
Prior art date
Application number
DK19161351.2T
Other languages
English (en)
Inventor
Zarnardi Andrea
Franco Gasparri
Raffaella Mantegazza
Martina Beltrandi
Original Assignee
Rottapharm Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rottapharm Ltd filed Critical Rottapharm Ltd
Application granted granted Critical
Publication of DK3524255T3 publication Critical patent/DK3524255T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/76—Salicaceae (Willow family), e.g. poplar
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/042—Gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/345—Alcohols containing more than one hydroxy group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A61K8/602—Glycosides, e.g. rutin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005—Antimicrobial preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/008—Preparations for oily skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/10—Washing or bathing preparations
DK19161351.2T 2015-02-27 2016-02-23 Sammensætning til behandling af acne DK3524255T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP15000576.7A EP3061501A1 (en) 2015-02-27 2015-02-27 Composition for the treatment of acne
EP16706531.7A EP3261726B1 (en) 2015-02-27 2016-02-23 Composition for the treatment of acne

Publications (1)

Publication Number Publication Date
DK3524255T3 true DK3524255T3 (da) 2020-11-09

Family

ID=52633039

Family Applications (2)

Application Number Title Priority Date Filing Date
DK16706531.7T DK3261726T3 (da) 2015-02-27 2016-02-23 Sammensætning til behandling af acne
DK19161351.2T DK3524255T3 (da) 2015-02-27 2016-02-23 Sammensætning til behandling af acne

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK16706531.7T DK3261726T3 (da) 2015-02-27 2016-02-23 Sammensætning til behandling af acne

Country Status (13)

Country Link
US (2) US20180021229A1 (da)
EP (4) EP3061501A1 (da)
CN (2) CN107257688A (da)
DK (2) DK3261726T3 (da)
ES (2) ES2835302T3 (da)
HR (2) HRP20191011T1 (da)
HU (2) HUE051654T2 (da)
PL (2) PL3524255T3 (da)
PT (1) PT3261726T (da)
RU (1) RU2718919C1 (da)
SI (2) SI3261726T1 (da)
TR (1) TR201908954T4 (da)
WO (1) WO2016134846A1 (da)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109952087B (zh) * 2017-06-05 2022-09-27 宝洁公司 包含使皮脂改性的材料的毛发护理组合物
CN111511343A (zh) * 2017-12-19 2020-08-07 帝斯曼知识产权资产管理有限公司 局部组合物
CA3105523A1 (en) * 2018-07-18 2020-01-23 Symrise Ag A detergent composition
CN108553411B (zh) 2018-07-25 2020-05-12 成都卓阳生物科技有限公司 壬二酸凝胶剂及其制备方法和应用
WO2021063527A1 (en) * 2019-10-03 2021-04-08 S-Biomedic Novel skin care composition
EP4037655A1 (en) * 2019-10-03 2022-08-10 S-Biomedic Novel skin care composition
MX2022004048A (es) * 2019-10-03 2022-05-02 S Biomedic Composicion novedosa para el cuidado de la piel.
WO2021063530A1 (en) * 2019-10-03 2021-04-08 S-Biomedic Novel skin care composition
CN114929196A (zh) * 2019-10-03 2022-08-19 S-生物医药有限公司 新的皮肤护理组合物
US20220401352A1 (en) * 2019-11-21 2022-12-22 Conopco, Inc., D/B/A Unilever A cosmetic composition
CN110893160B (zh) * 2019-12-14 2022-04-26 广州尚妆优品生物科技有限公司 修复组合物
CN114272298A (zh) * 2021-11-12 2022-04-05 河南省农业科学院畜牧兽医研究所 一种柳树皮提取物、其复方制剂及应用

Family Cites Families (81)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3173876A (en) 1960-05-27 1965-03-16 John C Zobrist Cleaning methods and compositions
US3276586A (en) 1963-08-30 1966-10-04 Rosaen Filter Co Indicating means for fluid filters
US3546142A (en) 1967-01-19 1970-12-08 Amicon Corp Polyelectrolyte structures
US3541006A (en) 1968-07-03 1970-11-17 Amicon Corp Ultrafiltration process
US3541005A (en) 1969-02-05 1970-11-17 Amicon Corp Continuous ultrafiltration of macromolecular solutions
US3813384A (en) 1972-01-17 1974-05-28 Asta Werke Ag Chem Fab Basically substituted benzyl phthalazone derivatives,acid salts thereof and process for the production thereof
US3854770A (en) 1972-11-20 1974-12-17 Pioneer Coveralls Inc Truck cover
US4077407A (en) 1975-11-24 1978-03-07 Alza Corporation Osmotic devices having composite walls
US4235236A (en) 1979-02-12 1980-11-25 Alza Corporation Device for dispensing drug by combined diffusional and osmotic operations
US4455143A (en) 1982-03-22 1984-06-19 Alza Corporation Osmotic device for dispensing two different medications
US4449983A (en) 1982-03-22 1984-05-22 Alza Corporation Simultaneous delivery of two drugs from unit delivery device
US4570630A (en) 1983-08-03 1986-02-18 Miles Laboratories, Inc. Medicament inhalation device
DE3575135D1 (de) 1984-09-14 1990-02-08 Asta Pharma Ag Substituierte benzylphthalazinon-derivate.
US5223493A (en) 1984-12-28 1993-06-29 Alcon Laboratories, Inc. Anti-inflammatory compounds for ophthalmic use
PT83094B (pt) 1985-07-30 1993-07-30 Glaxo Group Ltd Dispositivos proprios para a administracao de medicamentos a pacientes
ES2053678T3 (es) 1987-11-13 1994-08-01 Asta Medica Ag Procedimiento para preparar un medicamento con contenido de azelastina para la aplicacion nasal y/u ocular.
US5232919A (en) 1987-11-13 1993-08-03 Asta Pharma Aktiengesellschaft Azelastine embonate and compositions which contain it
US5271946A (en) 1988-04-20 1993-12-21 Asta Pharma Aktiengesellschaft Controlled release azelastine-containing pharmaceutical compositions
NZ234143A (en) 1989-06-28 1991-10-25 Mcneil Ppc Inc Aqueous pharmaceutical suspension formulation for administering substantially insoluble pharmaceutical agents
SG45171A1 (en) 1990-03-21 1998-01-16 Boehringer Ingelheim Int Atomising devices and methods
NO941358L (no) 1993-04-16 1994-10-17 Mcneil Ppc Inc Vandig farmasöytisk suspensjon og fremgangsmåte for fremstilling derav
DE4318455A1 (de) 1993-06-03 1994-12-08 Boehringer Ingelheim Kg Kapselhalterung
US5420120A (en) 1993-12-17 1995-05-30 Alcon Laboratories, Inc. Anti-inflammatory glucocorticoid compounds for topical ophthalmic use
US5897858A (en) 1994-02-03 1999-04-27 Schering-Plough Healthcare Products, Inc. Nasal spray compositions exhibiting increased retention in the nasal cavity
DE4438588A1 (de) * 1994-10-28 1996-05-02 Beiersdorf Ag Gegen unreine Haut, leichte Formen der Akne sowie Propionibacterium acnes wirksame Wirkstoffkombinationen auf der Basis von Wollwachssäuren und Glycerinestern gesättigter Fettsäuren
US5921237A (en) 1995-04-24 1999-07-13 Dura Pharmaceuticals, Inc. Dry powder inhaler
US5696267A (en) 1995-05-02 1997-12-09 Schering Corporation Substituted oximes, hydrazones and olefins as neurokinin antagonists
US5795894A (en) 1995-05-02 1998-08-18 Schering Corporation Piperazino derivatives as neurokinn antagonists
US5688960A (en) 1995-05-02 1997-11-18 Schering Corporation Substituted oximes, hydrazones and olefins useful as neurokinin antagonists
US5719156A (en) 1995-05-02 1998-02-17 Schering Corporation Piperazino derivatives as neurokinin antagonists
US5654316A (en) 1995-06-06 1997-08-05 Schering Corporation Piperidine derivatives as neurokinin antagonists
NZ310990A (en) 1995-06-21 2000-03-27 Asta Medica Ag Pharmaceutical powder cartridge, with an integrated metering slide, and inhaler therefor
DE19523516C1 (de) 1995-06-30 1996-10-31 Asta Medica Ag Inhalator zum Verabreichen von Medikamenten aus Blisterpackungen
DE19536902A1 (de) 1995-10-04 1997-04-10 Boehringer Ingelheim Int Vorrichtung zur Hochdruckerzeugung in einem Fluid in Miniaturausführung
DE19615577A1 (de) 1996-04-19 1997-10-23 Beiersdorf Ag Verwendung von Salicin als antiirritativer Wirkstoff in kosmetischen und topischen dermatologischen Zubereitungen
DE19617487A1 (de) 1996-05-02 1997-11-06 Merck Patent Gmbh Geschmacksverbesserung von Arzneimittelwirkstoffen
US5691362A (en) 1996-06-05 1997-11-25 Schering-Plough Corporation Substituted benzene-fused hetero- and carbocyclics as nuerokinin antagonists
US5789422A (en) 1996-10-28 1998-08-04 Schering Corporation Substituted arylalkylamines as neurokinin antagonists
US5783579A (en) 1996-12-20 1998-07-21 Schering Corporation Spiro-substituted azacyclic-substituted piperazino derivatives as neurokinin antagonists
DE19814256A1 (de) 1998-03-31 1999-10-07 Asta Medica Ag Feste, schnellzerfallende Cetirizin-Formulierungen
US6260549B1 (en) 1998-06-18 2001-07-17 Clavius Devices, Inc. Breath-activated metered-dose inhaler
JP2000012864A (ja) 1998-06-22 2000-01-14 Semiconductor Energy Lab Co Ltd 半導体装置の作製方法
US6270790B1 (en) 1998-08-18 2001-08-07 Mxneil-Ppc, Inc. Soft, convex shaped chewable tablets having reduced friability
US6319513B1 (en) 1998-08-24 2001-11-20 The Procter & Gamble Company Oral liquid mucoadhesive compounds
US6576677B1 (en) 1998-08-28 2003-06-10 Eisai Co., Ltd. Medicinal compositions with relieved bitterness
US6596298B2 (en) 1998-09-25 2003-07-22 Warner-Lambert Company Fast dissolving orally comsumable films
US6165512A (en) 1998-10-30 2000-12-26 Fuisz Technologies Ltd. Dosage forms containing taste masked active agents
US6552024B1 (en) 1999-01-21 2003-04-22 Lavipharm Laboratories Inc. Compositions and methods for mucosal delivery
US6615826B1 (en) 1999-02-26 2003-09-09 3M Innovative Properties Company Slow spray metered dose inhaler
MXPA02005007A (es) 1999-11-18 2004-08-12 Alcon Inc Uso de un antagonista h1 y un esteroide inocuo para tratar condiciones oculares.
WO2001052818A1 (en) 2000-01-19 2001-07-26 Pharmaceutical Discovery Corporation Dry powder formulations of antihistamine for nasal administration
US6427688B1 (en) 2000-02-01 2002-08-06 Dura Pharmaceuticals, Icn. Dry powder inhaler
DE10034328A1 (de) 2000-07-14 2002-01-31 Fribad Cosmetics Gmbh Kosmetisches Mittel zur äußeren Anwendung auf der Haut und deren Verwendung
US6620438B2 (en) 2001-03-08 2003-09-16 Boehringer Ingelheim Pharma Kg Pharmaceutical compositions based on anticholinergics and NK1-receptor antagonists
US7776315B2 (en) 2000-10-31 2010-08-17 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmaceutical compositions based on anticholinergics and additional active ingredients
WO2002056876A2 (en) 2001-01-18 2002-07-25 Medpointe Healthcare Inc. Treatment for snoring
FR2823671B1 (fr) * 2001-04-23 2004-01-09 Dermaconcept Jmc Composition dermatologique comprenant l'acide nicotinique ou un amide, et une base sphingoide
US20030013675A1 (en) 2001-05-25 2003-01-16 Boehringer Ingelheim Pharma Kg Combination of an adenosine A2A-receptor agonist and tiotropium or a derivative thereof for treating obstructive airways and other inflammatory diseases
US6681768B2 (en) 2001-06-22 2004-01-27 Sofotec Gmbh & Co. Kg Powder formulation disintegrating system and method for dry powder inhalers
US6779520B2 (en) 2001-10-30 2004-08-24 Iep Pharmaceutical Devices Inc. Breath actuated dry powder inhaler
US6723348B2 (en) 2001-11-16 2004-04-20 Ethypharm Orodispersible tablets containing fexofenadine
DE10206759A1 (de) 2002-02-19 2003-08-28 Dragoco Gerberding Co Ag Synergistische Mischungen von 1,2-Alkandiolen
ATE388693T1 (de) 2002-04-04 2008-03-15 Pfizer Prod Inc Wohlschmeckende kautablette
DE10215553A1 (de) * 2002-04-09 2003-12-24 Robugen Gmbh Weidenextrakt
JP2006525308A (ja) 2003-05-02 2006-11-09 ワーナー−ランバート カンパニー リミティド ライアビリティー カンパニー 耐熱性および耐湿性が改善された変性デンプンを含有する速溶性の経口消耗フィルム
US20040265372A1 (en) 2003-06-27 2004-12-30 David Wynn Soft tablet containing high molecular weight cellulosics
DE10341179A1 (de) * 2003-09-06 2005-03-31 Beiersdorf Ag Wirkstoffkombination gegen Akne
RU2259814C2 (ru) * 2003-10-30 2005-09-10 Халюта Алексей Иванович Крем для кожи
SE0303569L (sv) 2003-12-03 2005-06-04 Microdrug Ag DPI för avlämning av fuktkänsliga medikament
SE0303570L (sv) 2003-12-03 2005-06-04 Microdrug Ag Fukt-känslig medicinsk produkt
SE0303571D0 (sv) 2003-12-03 2003-12-22 Microdrug Ag Medical product for moisture-sensitive medicaments
FR2904765A1 (fr) * 2006-08-10 2008-02-15 Oreal Film a dissolution amelioree et produit cosmetique le contenant
EP1915982A1 (de) * 2006-10-20 2008-04-30 Symrise GmbH & Co. KG Verwendung von 1,2-Decandiol zur Sebumreduktion bzw. zur Unterstützung des Eindringens von Wirkstoffen in Hautbereiche, sowie kosmetische und/oder dermatologische Zubereitungen umfassend 1,2-Decandiol
US9687429B2 (en) * 2007-06-20 2017-06-27 The Trustees Of Columbia University In The City Of New York Antimicrobial compositions containing low concentrations of botanicals
WO2009046116A1 (en) * 2007-10-01 2009-04-09 Dennis Gross Skin care products containing multiple enhancers
KR20110015462A (ko) * 2008-06-05 2011-02-15 리차드 이. 데이비슨 나노은을 포함하는 여드름 치료 조성물 및 이의 용도
US20100129465A1 (en) * 2008-07-03 2010-05-27 Roger Blotsky Methods and Compositions Related to Acne Treatment
DE102010012384A1 (de) 2010-03-22 2011-09-22 Beiersdorf Ag Hautfreundliche Wirkstoffkombination gegen Akne
US9056063B2 (en) * 2012-03-13 2015-06-16 James E. Hanson Natural sunscreen composition
DE102012223401A1 (de) * 2012-12-17 2014-06-18 Henkel Ag & Co. Kgaa Emulsion mit antibakteriellem Wirkstoff
CN103816165B (zh) * 2014-03-11 2019-03-01 北京德默高科医药技术有限公司 一种治疗痤疮的组合物

Also Published As

Publication number Publication date
HRP20191011T1 (hr) 2019-08-23
HRP20201751T1 (hr) 2020-12-25
WO2016134846A1 (en) 2016-09-01
EP3524255B1 (en) 2020-09-09
DK3261726T3 (da) 2019-06-24
CN107257688A (zh) 2017-10-17
ES2731286T3 (es) 2019-11-14
HUE051654T2 (hu) 2021-03-29
TR201908954T4 (tr) 2019-07-22
PL3524255T3 (pl) 2021-03-08
SI3261726T1 (sl) 2019-09-30
EP3261726A1 (en) 2018-01-03
EP3524255A1 (en) 2019-08-14
EP3799933A1 (en) 2021-04-07
EP3261726B1 (en) 2019-04-17
RU2718919C1 (ru) 2020-04-15
EP3061501A1 (en) 2016-08-31
US20180021229A1 (en) 2018-01-25
SI3524255T1 (sl) 2021-02-26
ES2835302T3 (es) 2021-06-22
HUE044021T2 (hu) 2019-09-30
PL3261726T3 (pl) 2019-10-31
PT3261726T (pt) 2019-06-25
CN116019751A (zh) 2023-04-28
US20190175467A1 (en) 2019-06-13

Similar Documents

Publication Publication Date Title
DK3288581T3 (da) Fremgangsmåde til behandling af cancer
DK3192902T3 (da) Fremgangsmåde til fremstilling af graphenholdige viscosefibre
DK3377516T3 (da) Sammensætning til behandling af cancer
DK3286311T3 (da) Fremgangsmåde til behandling af maligniteter
DK3492632T3 (da) Metoder til behandling af lithiumholdige materialer
DK3102673T3 (da) Fremgangsmåder og sammensætninger til behandling af beta-talassæmi
DK3096741T3 (da) Fremgangsmåde til fremstillingen af hybridosomer
DK3439635T3 (da) Formuleringer til behandling af fast tumor
DK3125875T3 (da) Inhalerbar rapamycinformulering til behandling af aldersrelaterede tilstande
DK3524255T3 (da) Sammensætning til behandling af acne
DK3325443T3 (da) Fremgangsmåde til fremstilling af pridopidin
DK3174858T3 (da) Fremgangsmåde til fremstilling af pyrazoler
DK3362066T3 (da) Kombinationsterapi til behandling af maligniteter
DK3317400T3 (da) Fremgangsmåde til kryokonservering af tumorinfiltrerende lymfocytter
DK3148529T3 (da) Forbindelser til behandling af hjernecancer
DK3240612T3 (da) Fremgangsmåder til behandling af nethindesygdomme
DK3102555T3 (da) Sammensætninger af forbindelser og anvendelser deraf
DK3157534T3 (da) Acetylcholinesterasehæmmere til behandling af dermatologiske tilstande
DK3307267T3 (da) Behandling af multipel sklerose
DK3280408T3 (da) Fremgangsmåde til fremstilling af dicycloplatin
DK3528902T3 (da) Ringegelsammensætning
DK3261661T3 (da) Menotropin til behandling af infertilitet
DK3478713T3 (da) Sammensætninger til behandling af amyloidose
DK3122349T3 (da) Sammensætninger til behandling af autodigestion
DK3302573T3 (da) Sammensætning til behandlingen af hjernelæsioner